Equine Healthcare Market
Equine Healthcare Market Size, Share & Trends Analysis Report by Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others), by Product (Vaccines, Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics), Medicinal Feed Additives, Diagnostics, and Others), and by Distribution Channel (Veterinary hospital pharmacies and E-commerce) Forecast Period (2024-2031)
Equine healthcare market is anticipated to grow at a CAGR of 6.1% during the forecast period (2024-2031). The market growth is driven by the increasing animal health spending, accelerating prevalence of equine diseases, and increasing uptake of animal insurance. Additionally, the rise in demand for the use of horses for various purposes such as sports events, is also contributing significantly towards the market growth. The market will also grow owing to the rise in the equine population.
Market Dynamics
Increasing Equine Diseases
The global prevalence of diseases such as equine influenza, equine infectious anemia, rabies, west Nile fever, and Venezuelan equine encephalomyelitis drives the equine healthcare market. They pose serious health risks to horses and may require expensive treatments. Equine influenza is a highly communicable respiratory infection, whereas equine viral infectious anemia has no immunization and therefore requires strict prevention measures. Similarly, rabies can be potentially fatal and be treated through vaccination. Therefore, thorough R&D in the equine healthcare sector becomes necessary, to address the emerging need for vaccines, medicine, and effective disease control mechanisms that are vital in fighting against these diseases.
Adapting to Lifestyle Changes
Horses are used for horseback riding, trail riding, equestrian competitions, and more. This increases the expenditure on preventive medicine, veterinary care, and specialized treatments, leading to significant enhancement of equine healthcare market growth. The rising consciousness of horse health leads to increased needs for different medical products such as vaccinations, anthelmintics, osteoarthritis meds as well as veterinary care. Expansion in the number of horse-related hobbies has also increased opportunities for goods and services connected with horses, which has had a positive effect on the field of equine pharmacy. The rising recognition of activities associated with horses adds up to their increased adoption and a consequent rise in treatment measures.
Market Segmentation
Our in-depth analysis of the global equine healthcare market includes the following segments indication, product, and distribution channel.
- Based on indication, the market is segmented into musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, west Nile virus, tetanus, and others.
- Based on product, the market is segmented into vaccines, pharmaceuticals (parasiticides, anti-infectives, anti-inflammatory & analgesics), medicinal feed additives, diagnostics, and others.
- Based on the distribution channel, the market is bifurcated into veterinary hospital pharmacies and e-commerce.
Veterinary Hospitals Pharmacies Lead Distribution
Veterinary hospitals and pharmacies lead the distribution channel. There has been a notable rise in the total count of veterinarians and related medical facilities. Such growth rates in veterinary infrastructures enhance the accessibility of horse care services and create conditions for market expansion.
Pharmaceuticals Segment to Hold a Considerable Market Share
The pharmaceuticals segment is anticipated to hold a considerable share of the global equine healthcare market. Reproductive, metabolic, infectious, and dermatological disorders, analgesics, anti-infectives, anti-inflammatory, and parasiticides are among the many equine pharmaceuticals. Rising horse lovers and general horse wellness budgets have caused the demand for over-the-counter and prescription drugs to increase. This is made possible through initiatives that have been taken by market players. For instance, Zoetis offers various medications, such as QUEST gel, Equest Pramox, Deosect 5% Spray Solution, and more.
Regional Outlook
The global equine healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Rapid Growth Expected in Asia-Pacific
The Asia-Pacific region is anticipated to witness a significant rise in the equine healthcare market which is estimated to be over 6.0% during the anticipated timeframe indicating raised demand for horse medical feeds as well as increased cases of equine diseases besides public policies aimed at enhancing equine health. In the equine products market, the region's growth trajectory will mainly be influenced by a considerable number of market players. The demand for distinctive equine feeds and pharmaceutical interventions will increase as horse owners make nutrition and veterinary care a priority. Government policies that aim at improving veterinary infrastructure and surveillance of diseases have also been contributing to the growth of the market. In general, the APAC region affords significant investment and growth potential in the field of equine healthcare supported by rising demand and government measures.
Global Equine Healthcare Market Growth by Region 2024-2031
North America Holds Major Market Share
North America dominates the market owing to the high population of equines in the US. The region is also home to a vibrant equine industry, with horse farms and horse-related sports. In addition, the import of horses in the region highlights the growing sector and brings about the resultant demand for medical remedies.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global equine healthcare market include Bayer AG, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Virbac S.A., and Zoetis Services LLC, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global equine healthcare market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Bayer AG
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Boehringer Ingelheim International GmbH
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Merck & Co., Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Virbac S.A.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Zoetis Services LLC
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Equine Healthcare Market by Indication
4.1.1. Musculoskeletal Disorders
4.1.2. Parasite Control
4.1.3. Equine Herpes Virus
4.1.4. Equine Encephalomyelitis
4.1.5. Equine Influenza
4.1.6. West Nile Virus
4.1.7. Tetanus
4.1.8. Others (Rabies)
4.2. Global Equine Healthcare Market by Product
4.2.1. Vaccines
4.2.2. Pharmaceuticals
1.1.1. Parasiticides
1.1.2. Anti-infectives
1.1.3. Anti-inflammatory & Analgesics
4.2.3. Medicinal Feed Additives
4.2.4. Diagnostics
4.2.5. Others (Software & Services)
4.3. Global Equine Healthcare Market by Distribution Channel
4.3.1. Veterinary hospital pharmacies
4.3.2. E-commerce
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. Ceva Animal Health, LLC
6.2. Dechra Veterinary Products Limited
6.3. Elanco Animal Health Inc.
6.4. Equine Products UK Ltd
6.5. ESAOTE SPA
6.6. Hallmarq Veterinary Imaging Ltd.
6.7. Heska Corp.
6.8. IDEXX Laboratories, Inc.
6.9. Krka, tovarna zdravil, d.d., Novo mesto
6.10. Luitpold Pharmaceuticals, Inc.
6.11. Neogen
6.12. Norbrook Group
6.13. Vetoquinol Group
1. GLOBAL EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2023-2031 ($ MILLION)
2. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR MUSCULOSKELETAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
3. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR PARASITE CONTROL MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
4. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE HERPES VIRUS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
5. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE ENCEPHALOMYELITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
6. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE INFLUENZA MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
7. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR WEST NILE VIRUS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
8. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR TETANUS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
9. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
10. GLOBAL EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
11. GLOBAL EQUINE VACCINES PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
12. GLOBAL EQUINE PHARMACEUTICALS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
13. GLOBAL EQUINE MEDICINAL FEED ADDITIVES PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
14. GLOBAL EQUINE DIAGNOSTICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
15. GLOBAL EQUINE OTHERS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
16. GLOBAL EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2023-2031 ($ MILLION)
17. GLOBAL EQUINE HEALTHCARE PRODUCTS IN VETERINARY HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
18. GLOBAL EQUINE HEALTHCARE PRODUCTS IN E-COMMERCE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
19. GLOBAL EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
20. NORTH AMERICAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
21. NORTH AMERICAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2023-2031 ($ MILLION)
22. NORTH AMERICAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
23. NORTH AMERICAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2023-2031 ($ MILLION)
24. EUROPEAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
25. EUROPEAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2023-2031 ($ MILLION)
26. EUROPEAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
27. EUROPEAN EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2023-2031 ($ MILLION)
28. ASIA-PACIFIC EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
29. ASIA-PACIFIC EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2023-2031 ($ MILLION)
30. ASIA-PACIFIC EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
31. ASIA-PACIFIC EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2023-2031 ($ MILLION)
32. REST OF THE WORLD EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
33. REST OF THE WORLD EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2023-2031 ($ MILLION)
34. REST OF THE WORLD EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
35. REST OF THE WORLD EQUINE HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2023-2031 ($ MILLION)
1. GLOBAL EQUINE HEALTHCARE MARKET SHARE BY INDICATION, 2023 VS 2031 (%)
2. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR MUSCULOSKELETAL DISORDERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
3. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR PARASITE CONTROL MARKET SHARE BY REGION, 2023 VS 2031 (%)
4. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE HERPES VIRUS MARKET SHARE BY REGION, 2023 VS 2031 (%)
5. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE ENCEPHALOMYELITIS MARKET SHARE BY REGION, 2023 VS 2031 (%)
6. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR EQUINE INFLUENZA MARKET SHARE BY REGION, 2023 VS 2031 (%)
7. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR WEST NILE VIRUS MARKET SHARE BY REGION, 2023 VS 2031 (%)
8. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR TETANUS MARKET SHARE BY REGION, 2023 VS 2031 (%)
9. GLOBAL EQUINE HEALTHCARE PRODUCTS FOR OTHERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
10. GLOBAL EQUINE HEALTHCARE MARKET SHARE BY PRODUCT, 2023 VS 2031 (%)
11. GLOBAL EQUINE VACCINES PRODUCTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
12. GLOBAL EQUINE PHARMACEUTICALS PRODUCTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
13. GLOBAL EQUINE MEDICINAL FEED ADDITIVES PRODUCTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
14. GLOBAL EQUINE DIAGNOSTICS PRODUCTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
15. GLOBAL EQUINE HEALTHCARE MARKET SHARE BY DISTRIBUTION CHANNEL, 2023 VS 2031 (%)
16. GLOBAL EQUINE HEALTHCARE PRODUCTS IN VETERINARY HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
17. GLOBAL EQUINE HEALTHCARE PRODUCTS IN E-COMMERCE MARKET SHARE BY REGION, 2023 VS 2031 (%)
18. GLOBAL EQUINE HEALTHCARE MARKET SHARE BY REGION, 2023 VS 2031 (%)
19. US EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
20. CANADA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
21. UK EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
22. FRANCE EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
23. GERMANY EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
24. ITALY EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
25. SPAIN EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
26. REST OF EUROPE EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
27. INDIA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
28. CHINA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
29. JAPAN EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
30. SOUTH KOREA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
31. REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
32. LATIN AMERICA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
33. MIDDLE EAST AND AFRICA EQUINE HEALTHCARE MARKET SIZE, 2023-2031 ($ MILLION)
